November 4, 2015 / 3:36 PM / in 2 years

BUZZ-Retrophin Inc: U.S. senators probe drug pricing

(Updates)

** Drugmaker's shares down 16 pct at $18.23

** Two U.S. senators launched a bipartisan investigation into pharmaceutical drug pricing on Wednesday, requesting documents from four drugmakers, including Retrophin and Valeant Pharmaceuticals International Inc

** Valeant's U.S.-listed shares down about 1.1 pct at $96.82

** The other companies being investigated are privately held Turing Pharmaceuticals and Rodelis Therapeutics

** Shares of many drugmakers have slumped since Democratic presidential hopeful Hillary Clinton last month proposed ways to prevent industry "profiteering.

** Up to Tuesday's close, Retrophin's stock had fallen about 24 pct since Sept. 21 when Clinton tweeted her intent to tackle unnecessarily high prices in some drug markets

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below